Biologics Distributor for Waco, Texas Medspas and Aesthetic Practices

Documentation a Waco medspa should request before adding a product line

Medspas and aesthetic practices considering a new Wharton's jelly or exosome product typically ask for a certificate of analysis, donor eligibility summary, and sterility testing results for the specific lot, along with confirmation that registration and licensure documentation exists and can be produced on request.

Because these are not FDA-approved products, we also recommend reviewing FDA's public statements on regenerative medicine products and exosomes directly, and having the practice's own counsel confirm what disclosures or informed-consent language apply before any product is used in the practice.

Physician supervision and account setup

Because Precision Biologics sells only to licensed clinics, physicians, and medspas operating under physician supervision, a Waco medspa opens an account under an NPI number tied to the supervising physician or practice. This keeps ordering authority with a licensed professional even when day-to-day purchasing is handled by practice staff.

Account verification is a short step: submit the NPI, confirm the delivery location, and complete the verification check before pricing becomes visible.

Receiving shipments at a medspa or dermatology practice

Cryopreserved Wharton's jelly formats arrive overnight on dry ice in validated shipping containers and require a freezer and a documented receiving step; lyophilized exosome and Wharton's jelly formats are shelf-stable, which some smaller aesthetic practices find simpler to store and log.

Every shipment carries a lot identifier so the practice can record, at the patient-record level, exactly which lot was used.

Getting a Waco practice set up

We suggest confirming any planned use with the practice's supervising physician and checking applicable requirements with the Texas Medical Board and the practice's own counsel; Precision Biologics does not advise on procedures, dosing, or outcomes.

From there, a practice can request a documentation packet and schedule a peer-to-peer call on specifications before placing a first order.

FDA has stated there are no FDA-approved exosome products. Exosome products are generally regulated as biologic drugs under section 351 of the Public Health Service Act, not as 361 HCT/Ps. Purchase and clinical use decisions belong to the physician with their own regulatory counsel.

These products are not FDA approved or licensed for any disease or condition. Information is for licensed healthcare professionals and is not medical or legal advice.